These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9379099)

  • 21. [Chemotherapy of highly malignant thyroid tumors].
    Kober F; Heiss A; Keminger K; Depisch D
    Wien Klin Wochenschr; 1990 Apr; 102(9):274-6. PubMed ID: 2165340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytostatic drug therapy in anaplastic thyroid carcinoma.
    Wenisch HJ; Wagner RH; Schumm-Draeger PM; Encke A
    World J Surg; 1986 Oct; 10(5):762-9. PubMed ID: 3776213
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial.
    Williams SD; Birch R; Einhorn LH
    Cancer Treat Rep; 1986 Mar; 70(3):405-7. PubMed ID: 3955552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction chemotherapy in association with preoperative radiotherapy and cystectomy in bladder carcinoma--a preliminary report.
    Andersson L; Esposti PL; Fosså SD; Sander S
    Prog Clin Biol Res; 1988; 260():621-3. PubMed ID: 3362910
    [No Abstract]   [Full Text] [Related]  

  • 25. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
    Schuhmacher CP; Fink U; Becker K; Busch R; Dittler HJ; Mueller J; Siewert JR
    Cancer; 2001 Mar; 91(5):918-27. PubMed ID: 11251943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [European School of Oncology (ESO)--gastric cancer treatment strategy].
    Ogawa M
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):277-9. PubMed ID: 1736843
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of EAP (etoposide, adriamycin, cis-platinum) on patients with advanced gastric cancer: the role of EAP as neoadjuvant chemotherapy and histopathological study on its effect].
    Tsujinaka T; Murata A; Ogawa M; Kido Y; Shiozaki H; Miyamoto T; Kanbayashi J; Kobayashi K; Tahara H; Miyata M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3295-8. PubMed ID: 2782922
    [No Abstract]   [Full Text] [Related]  

  • 28. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution.
    Baroli A; Pedrazzini L; Lomuscio G; Marzoli L
    Minerva Endocrinol; 2010 Mar; 35(1):9-16. PubMed ID: 20386523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of platinum dose intensity in first-line therapy on subsequent disease follow-up of epithelial ovarian carcinoma].
    Gruböck K
    Wien Klin Wochenschr; 1994; 106(11):362-6. PubMed ID: 8053205
    [No Abstract]   [Full Text] [Related]  

  • 30. [Multimodality therapy for small-cell lung cancer].
    Yokoyama A
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():405-11. PubMed ID: 9369915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
    Navarro M; Mur E; Jolis L; Bellmunt J; Bodi R; Solé LA; Rubio D
    Rev Clin Esp; 1991 Oct; 189(5):209-12. PubMed ID: 1666192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of surgical treatment in the combination therapy of small cell lung cancer (SCLC)].
    Yamaguchi Y; Momiki S; Kimura H; Ogawa T; Baba M
    Kyobu Geka; 1988 Mar; 41(3):184-9. PubMed ID: 2838669
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trials referral resource. Small-cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1990 Jan; 4(1):43-56. PubMed ID: 2168198
    [No Abstract]   [Full Text] [Related]  

  • 35. [Squamous cell cancer of the esophagus. Treatment concept at the Houston M.D. Anderson Cancer Center].
    Roth JA
    Chirurg; 1992 Sep; 63(9):683-8. PubMed ID: 1395872
    [No Abstract]   [Full Text] [Related]  

  • 36. Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen.
    Chung HC; Roh JK; Park YJ; Lee SI; Min JS; Lee JT; Lee KB; Kim BS
    Yonsei Med J; 1990 Mar; 31(1):74-9. PubMed ID: 2346043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma.
    Agatsuma T; Koizumi T; Kanda S; Ito M; Urushihata K; Yamamoto H; Hanaoka M; Kubo K
    J Thorac Oncol; 2011 Dec; 6(12):2130-4. PubMed ID: 21892103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Etoposide, pirarubicin and cisplatin(ETP) combined therapy of inoperable head and neck cancer].
    Kawakami T; Watanabe S; Ogawara T; Akagi S; Tamura S; Koide I; Ogawa A; Takiguchi S; Masuda Y
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):669-72. PubMed ID: 8470928
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy of thyroid carcinoma.
    Ahuja S; Ernst H
    J Endocrinol Invest; 1987 Jun; 10(3):303-10. PubMed ID: 3624802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy of neuroendocrine tumors].
    Droz JP; Flechon A; Lombard-Bohas C
    Rev Prat; 2002 Feb; 52(3):285-9. PubMed ID: 11925719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.